KIMBERLY WARDON: Open Payments
NPI 1295376937 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 15 payments from 9 companies in 2025. Trend: 2023 $41 · 2024 $308 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 4 | $51 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Sage Therapeutics, LLC | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Azstarys, Auvelity, COBENFY, ZURZUVAE, CAPLYTA, AUSTEDO XR, FANAPT, INVEGA SUSTENNA.
Industry payments across WI — which companies pay providers there.
